Evaluate ARWR stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ARWR? | Glauxie AI

Q: What are the risks of investing in ARWR?

Arrowhead Pharmaceuticals, Inc. (ARWR) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Christopher R. Anzalone. Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi)... Employees: 711.

Q: How much debt does ARWR have?

Review ARWR total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ARWR a good long-term investment?

Evaluate ARWR as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ARWR?

🦉

Arrowhead Pharmaceuticals, Inc. (ARWR)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOChristopher R. Anzalone

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated...

Key Executives

Name	Title
Aaron Tan	Head of Tax
Bruce D. Given	Chief Medical Scientist
Christopher R. Anzalone	Chairman, Chief Executive Officer & President
Daniel J. Apel	Chief Financial Officer
Howard Lovy	Director of Communications
James C. Hamilton	Chief Medical Officer and Head of R&D

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ARWR Profile Financials

Is ARWR stock safe? How much debt does ARWR have? Is ARWR a good long-term investment?